Improving Diagnostics and Patient Outcomes in The USA Using Bioengineering Techniques

References

[1] Ardila, D., et al. (2019). End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nature Medicine, 25(6), 954–961. https://doi.org/10.1038/s41591-019-0447-x

[2] Atala, A. (2006). Tissue engineering: Current status and future directions. The American Journal of Medicine, 119(5), S10–S16. https://doi.org/10.1016/j.amjmed.2006.06.015

[3] Clark, L. C., & Lyons, C. (1962). Electrode systems for continuous monitoring in cardiovascular surgery. Annals of the New York Academy of Sciences, 102(1), 29–45. https://doi.org/10.1111/j.1749-6632.1962.tb13623.x

[4] Clark Jr, L. C., & Lyons, C. (1989). Electrode systems for continuous monitoring in cardiovascular surgery. Annals of the New York Academy of Sciences, 572(1), 107–120. https://doi.org/10.1111/j.1749-6632.1989.tb14196.x

[5] Esteva, A., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118. https://doi.org/10.1038/nature21056

[6] Giacomini, K. M., et al. (2012). Personalized medicine for the European Union. Nature Reviews Drug Discovery, 11(12), 943–944. https://doi.org/10.1038/nrd3846

[7] Gootenberg, J. S., et al. (2018). Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 360(6387), 439–444. https://doi.org/10.1126/science.aaq0179

[8] Gulshan, V., et al. (2016). Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA, 316(22), 2402–2410. https://doi.org/10.1001/jama.2016.17216

[9] Hacein-Bey-Abina, S., et al. (2000). LMO2-associated clonal T cell proliferation in two patients receiving gene therapy for X-linked severe combined immunodeficiency. Science, 288(5466), 669–672. https://doi.org/10.1126/science.288.5466.669

[10] Heineman, W. R., & Halsall, H. B. (2000). Bioanalytical chemistry: An introduction. Oxford University Press.

[11] Hubbard, A. J., & Cannizzaro, S. M. (2003). Biomaterials for tissue engineering. Advanced Drug Delivery Reviews, 55(12), 1553–1571. https://doi.org/10.1016/j.addr.2003.08.012

[12] June, C. H., et al. (2018). CAR T cell immunotherapy for hematologic malignancies: Bridging the gap between science and patients. Nature Medicine, 24(1), 51–64. https://doi.org/10.1038/nm.4441

[13] Kaplan, A., et al. (2020). Democratizing healthcare through affordable diagnostics. Healthcare Innovation Journal, 34(4), 56–62. https://doi.org/10.1016/j.hcij.2020.03.004

[14] Kellner, M. J., et al. (2019). SHERLOCK: Nucleic acid detection with CRISPR nucleases. Nature Protocols, 14(10), 2986–3012. https://doi.org/10.1038/s41596-019-0210-2

[15] Le Bihan, D. (2003). Diffusion MRI. Magnetic Resonance Imaging, 21(10), 1231–1241. https://doi.org/10.1016/S0730-725X(03)00215-2

[16] Lindner, J. R., & Ferrara, K. W. (2000). Microbubble contrast agents: Principles of generation and mechanisms of action. The American Journal of Roentgenology, 175(2), 313–323. https://doi.org/10.2214/ajr.175.2.1750313

[17] Lutolf, M. P., & Hubbell, J. A. (2005). Synthetic biomaterials as instructive extracellular microenvironments for tissue engineering. Nature Reviews Materials, 1(1), 15–27. https://doi.org/10.1038/nrm2224

[18] Mahmud, N., et al. (2018). Mobile health applications in chronic disease management. Journal of Medical Internet Research, 20(9), e119. https://doi.org/10.2196/jmir.7814

[19] Malda, J., et al. (2004). 3D tissue engineering: The potential of scaffold-free constructs. Trends in Biotechnology, 22(12), 559–568. https://doi.org/10.1016/j.tibtech.2004.09.004

[20] Martinez, A. W., et al. (2008). Microfluidic devices for integrated cell culture and analysis. Analytical Chemistry, 80(7), 2526–2542. https://doi.org/10.1021/ac702111x

[21] McKinney, S. M., et al. (2020). International evaluation of an AI system for breast cancer screening. Nature, 577(7788), 89–94. https://doi.org/10.1038/s41586-019-1799-6

[22] Parikh, R. B., et al. (2019). Addressing bias in artificial intelligence in health care. JAMA, 322(24), 2377–2378. https://doi.org/10.1001/jama.2019.18058

[23] Rao, C. R., et al. (2021). Wearable biosensors: Opportunities and challenges in real-time health monitoring. Sensors, 21(14), 4784. https://doi.org/10.3390/s21144784

[24] Syvanen, A. C. (2001). Accessing genetic variation: Genotyping single nucleotide polymorphisms. Nature Reviews Genetics, 2(1), 930–942. https://doi.org/10.1038/35057123

[25] Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7

[26] Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery, 4(2), 145–160. https://doi.org/10.1038/nrd1632

[27] Velikyan, I., et al. (2014). Molecular imaging of cancer: A review. Cancer Imaging, 14(1), 1–27. https://doi.org/10.1186/1470-7330-14-19

[28] Wang, J. (2008). Electrochemical glucose biosensors. Chemical Reviews, 108(2), 814–825. https://doi.org/10.1021/cr068123a

[29] Weissleder, R., & Ntziachristos, V. (2003). Shedding light onto live molecular targets. Nature Medicine, 9(1), 123–128. https://doi.org/10.1038/nm0103-123

[30] Weissleder, R., & Wittenberg, J. (2003). Color atlas of functional and molecular imaging. Academic Press.

[31] Whitesides, G. M. (2006). The origins and the future of microfluidics. Nature, 442(7101), 368–373. https://doi.org/10.1038/nature05058

[32] Zhu, H., et al. (2022). Emerging trends in bioengineering technologies for healthcare applications. Biomedical Engineering Advances, 3, 100056. https://doi.org/10.1016/j.bea.2022.100056

[33] +-26UVWhi•–—Ÿ¡— ­ ® ¯ íÚÚÚÚíÚíÏÀ´¢–‡uaMMM9&h=h=5�6�CJOJPJQJaJ&håK}h=5�6�CJOJPJQJaJ&håK}h^~ 5�6�CJOJPJQJaJ"håK}h^~ 5�6�CJOJQJaJh^~ h=CJOJQJaJh˜gCJOJQJaJ"håK}h=6�OJQJ]�mH sH h=OJQJmH sH h=h=OJQJmH sH h=h^~ OJQJ$h=håK}CJ(OJQJaJ(mH sH $h=h=CJ(OJQJaJ(mH sH VWi•–—® ¯ ¼ ½ €�ª«ÚõèõõÖÖÌÅ©ŸŸŸŸŸŠ$ &F„7„Éý¤^„7`„Éýa$gdåK} $¤a$gd=$ &F„ñÿ„7„Éýdì¤:]„ñÿ^„7`„Éýa$gdåK}¤gd= $¤a$gdåK}„ñÿ„ dð¤]„ñÿ^„ gd^~ $dð¤a$gd= $¤a$gd=¯ » ¼ ½ €�ª«ÙÚÛÚÚ‹Œ�§¨©Ú Ú"# ##Ú$ˆ&‰&Š&š&Õ&O'P'Q'['\']'/(0(Ü(³)/*�*7+ñåÙÊ»ÊÊÊÊÊÊÊÊÊÊÊÊÙÊÊÊÊÙÊÊÙÊÊÊÊÙ¬ÊÊÙÙÊÊÊÙÙ�‘‚ÊÊÊÊÊÊÊhôthåK}CJOJQJaJhôtCJOJQJaJh=hôtCJOJQJaJhA$ÇhA$ÇCJOJQJaJh=håK}CJOJQJaJh=h=CJOJQJaJh=CJOJQJaJh˜gCJOJQJaJh˜gh^~ CJOJQJaJ3ÚÛŒ�¨© ##‰&Š&š&Õ&P'Q'\']'ôêêÕÊêÂêê¸ê£•‡‡ [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]

[34] [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]

@article{1709059,
      author = {Yvonne Ilozuluike},
      title = {Improving Diagnostics and Patient Outcomes in The USA Using Bioengineering Techniques},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {8},
      number = {12},
      pages = {633-636},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1709059.pdf},
      abstract = {Medical diagnosis and personalized medicine in the United States have been greatly redefined due to the development of Bioengineering. The incorporation of Artificial intelligence, tissue engineering, biosensors have developed a better diagnostics process leading to early detection, precise diagnostics and personalized treatment processes. This research investigates the newest development in bioengineering and its benefits on patient outcome and the issues that are concerned with the implementation of these processes.},
      month = {June},
  }